Home > News > Latest > Etao International Group Announces Acquisition of Dnurse, a Provider of Technology-Empowered Diabetes Management Solutions

Digital Healthcare

Etao International Group Announces Acquisition of Dnurse, a Provider of Technology-Empowered Diabetes Management Solutions

ETAO International Group ("ETAO") announces the acquisition of Dnurse, a provider of digital diabetic management services. This innovative technology can improve outcomes for patients with diabetes and has the potential to be used in the treatment of all chronic diseases. The incidence of diabetes is increasing globally and has become a critical public health concern. In particular, diabetes has a leading public health challenge in China. According to the WHO, approximately 345 million individuals are afflicted with some form of diabetes in China. If left untreated, diabetes can lead to devastating complications, such as heart disease, nerve damage, blindness, kidney failure and amputations.

Dnurse provides patients with a technologically innovative self-management solution that increases compliance with critical treatment requirements, thereby improving patient outcomes. This new diabetic care combines people-first services with digital technology to remove limitations of traditional diabetic care.

Dr. Lee Winter, President of Etao International Group, has over 35 years of experience in healthcare as a former attending anesthesiologist and director of business development as Maimonides Medical Center Department of Anesthesiology and as former chair of the New York Presbyterian Lower Manhattan Hospital.

"Dnurse's low-cost, high-efficiency and easy-to-use diabetes self-management solution is extremely scalable and has the potential to significantly improve diabetic care. The digital interface increases client compliance, thereby reducing the risk of diabetic complications and improving patient outcomes. This cost-effective manner of efficiently preventing chronic disease complications has the potential to help patients manage any kind of chronic disease."

Dr. Lee Winter, President of Etao International Group

Leading this innovation solution is the co-founder and CEO of Dnurse, Jason Li. He has over 14 years of experience in the technology sector, including his role as the China CEO of Infosonics, VP of Techfaith Group and development engineer for Motorola. He said, "Dnurse plans to use the world's latest health care solutions and resources to serve the diabetic patients' needs. We are working with ETAO International Group to create a synergy that will secure a more sizable market presence, create a brand consistent with best diabetic care and reshape the established diabetic management landscape."

Founded in 2013, Dnurse was heavily invested by Sinocare and Innovation Works (now Sinovation Ventures), and SAIF. As the largest glucose meter manufacturer in Asia, Sinocare provides Dnurse with advanced biochemical technology, registration, delivery, and customization capacity.

Based on its Smart Glucose Meter, Dnurse has successfully built an innovation business model: Device + App + Service. Dnurse is also relying on its powerful AI decision system, IDSS (Intelligent Decision Support System), to make its diabetic management packages optimized for patients, burden-free, consistent, and humanistic. With the Dnurse App, a smart blood sugar testing meter can transfer information to a patient's smart phone. The mobile application allows for testing, data storage, personal feedback, sharing, customized reminders, and coaching, available to the patient every day and everywhere. Dnurse's smart diabetes care products are already serving 1.6 million diabetic patients.

About Etao International Group

Etao International Group ("Etao"), a Cayman Islands company, aims to be the world's leading digital healthcare group providing telemedicine, hospital care, primary care, pharmacy and health insurance covering all life stages of patients. "Etao" brand means "Best Medical Way" with transformative medical care and unparalleled service. Etao provides best-in-class internet medical services, such as artificial intelligence and big data technologies, to improve health care delivery and quality in specialized clinics and hospital settings. Etao's platform is seamlessly integrated because of its ability to combine technology and health sciences. Etao's US subsidiary was established in December 2017 in Delaware USA, and its wholly owned subsidiary Fangzhou Yidao (Beijing) Health Technology Co., Ltd. ("Etao China"), was established in Beijing in July 2019.

About Dnurse

Dnurse was founded in Beijing China in July 2013 and is the first Chinese innovation mobile medical company whose mission is to reform traditional diabetes management. Dnurse offers personalized and professional diabetes management solutions. Its IoT & AI technology effectively improves diabetics compliance and attracted 1.6 million diabetes users. Dnurse is the largest platform of diabetic patients in China, and the No.1 smart glucometer manufacturer in China and India. Its closed loop service consists of diabetes hospitals, providing patients online referral, online prescription, and drug purchase services. Low- cost and efficiency helps diabetics patients' self-management and improved patient compliance.

Spotlight

Other News

Health Technology

ShiftKey Extends Its Tech Solutions to Embrace Acute Care Facilities

ShiftKey | September 15, 2023

ShiftKey, a leading technological enterprise at the forefront of reshaping the future of workforce engagement, has officially announced its expansion into acute healthcare facilities. ShiftKey's technology, data resources, and talent marketplace are set to be accessible to acute care facilities in Kansas, Missouri, Tennessee, and Texas. This expansion addresses workforce-related challenges and enhances patients' access to top-tier healthcare services. Furthermore, the technology has already undergone beta testing at acute care facilities in Alabama, Louisiana, Nebraska, New Mexico, South Carolina, and West Virginia. CEO of ShiftKey, Mike Vitek, characterized the company's foray into the acute care sector as a pivotal step in its platform and business development. He emphasized the organization's vantage point on healthcare staffing challenges and expressed optimism regarding the potential alleviation of strain on acute care facilities and healthcare professionals. Meanwhile, Brandon Tappan, Chief Revenue Officer at ShiftKey, added that the escalating workforce challenges confronting healthcare facilities have become an annual trend. The departure of nurses from acute care facilities in large numbers underscores the imperative for a novel approach to address staffing needs within institutions serving vulnerable populations. Integrating ShiftKey's technology into acute care facilities represents establishing an independent healthcare staffing solution. This initiative aims to reinvigorate and safeguard this vital industry by enabling individuals to rejoin the workforce on their terms. About ShiftKey ShiftKey is a technological enterprise dedicated to transforming workforce access and integrity. Employing data and a marketplace model, the company facilitates connections between independent licensed professionals and facilities with workforce requirements. It is pivotal in advancing empowered labor, stability, and solutions for professionals, institutions, and beneficiaries. With a platform encompassing 10,000 healthcare facilities and myriad independently licensed professionals, ShiftKey is one of the foremost leaders in strategic workforce solutions, catalyzing a more sustainable, inclusive, and prosperous workforce economy for the years ahead.

Healthcare Analytics

WellSky Expands Post-Acute Offerings Through Corridor Acquisition

WellSky | October 13, 2023

WellSky has officially declared its acquisition of Corridor, a comprehensive technology-enabled service platform tailored to address the most formidable challenges in the post-acute care industry. This strategic move is intended to aid care providers in enhancing their efficiency and overall performance across various domains, encompassing clinical, financial, operational, and compliance aspects. The acquisition has been facilitated through the purchase of Corridor from HealthEdge Investment Partners, a private equity firm with a dedicated focus on healthcare. Bill Miller, CEO of WellSky, highlighted providers' need for quality care support and reduced administrative burdens. He stated, As we looked to strengthen our services offerings, Corridor emerged as an ideal partner. Together, WellSky and Corridor help more post-acute care organizations succeed against industry challenges. [Source – Business Wire] Des Varady, CEO of Corridor, expressed that for over three decades, Corridor has remained dedicated to its mission of enabling clients to optimize their performance and resources through robust technology-based solutions. He conveyed his enthusiasm for Corridor's continued commitment to advancing this mission as an integral part of the WellSky team. By gaining access to WellSky's technology-driven solutions, focusing on enhancing outcomes, reducing expenses, and enhancing patient and family satisfaction, Corridor is better positioned to serve its clients more effectively. With the integration of Corridor into its portfolio, WellSky aims to broaden its spectrum of services in medical coding and revenue cycle management. About WellSky Known for its proven software, analytics, and services, WellSky, a prominent U.S. healthcare technology company, drives better outcomes and cost savings across the healthcare and community care spectrum. It empowers providers, payers, health systems, and community organizations to streamline processes, enhance collaboration, leverage data analytics, and improve results by integrating clinical and social care. About Corridor The Corridor Group Holdings, LLC (Corridor) is a prominent post-acute healthcare sector entity offering top-tier technology-driven outsourced coding, revenue cycle, and educational solutions. It specializes in improving documentation quality and getting better client reimbursement outcomes, including for large health systems, national chains, and smaller, independently managed agencies.

Health Technology

Home Care Delivered, Inc. Completes Acquisition of Medline Industries, LP's DMEPOS Supplier Business Unit

PR Newswire | October 17, 2023

Home Care Delivered, Inc. a leader in providing medical supplies including diabetes/CGM, incontinence, wound, urological, and ostomy products, is excited to announce the successful acquisition of Medline Industries, LP's DMEPOS supplier business unit. This strategic move will significantly enhance HCD's market presence, expand its geographical footprint, and provide access to a broader customer base while reinforcing relationships with patients, healthcare plans and providers, and manufacturers. "The transaction represents a major milestone for HCD by leveraging over 25 years of distinguished expertise in medical supplies," said Gordy Fox, founder and chief executive officer of HCD. "This acquisition aligns with our commitment to delivering personalized and compassionate customer experiences while leveraging Medline's DMEPOS supplier assets, and continuing to provide our industry expertise and best-in-class customer service." said Brad Mariam, executive vice president, Medline. With the transition of Medline's DMEPOS supplier assets to HCD, a company that shares in our commitment to exceptional service and patient care, Medline will continue to focus on its core role as an industry leader in the manufacturing and distribution of quality medical supplies. [Source: PR Newswire] "By integrating Medline's DMEPOS supplier assets, we are accelerating our growth strategy, delivering an avenue for expanded cost-efficiencies and member adherence," said Lowell Price, senior vice president of business development and chief growth officer of HCD. "This strategic move aligns with our commitment to delivering superior customer service, additional product offerings and ensuring reliable delivery to our members. HCD is well-positioned to continue to elevate customer experiences and reinforce our market presence." About Home Care Delivered, Inc. Home Care Delivered is a leading direct-to-consumer provider of insurance-covered medical supplies of diabetes testing, incontinence, urology, ostomy and wound care supplies delivered directly to the patient's home. Founded in 1996 and headquartered in Glen Allen, Virginia, Home Care Delivered is dedicated to providing best-in-class customer support and quality supplies for patients and caregivers nationwide.

Health Technology, AI

Aidoc and Mayo Clinic Maximize Patient Care through AI Assistance

Aidoc | October 12, 2023

Aidoc, a pioneer in clinical AI technology, has entered into a collaborative partnership with Mayo Clinic Platform to enhance healthcare by facilitating access to Aidoc's AI technology and platform. Aidoc uses AI to help medical teams in charge of diagnosing, caring for, and treating patients stay in touch with each other. This ensures that essential data is always available to make smart decisions about healthcare interventions and what to do next. Ed Simcox, Vice President of Solutions at Mayo Clinic Platform, confirmed that Aidoc is well-positioned to deal with several common issues with AI-based healthcare solutions, such as the costs of implementing them only once. By eliminating these barriers, healthcare providers of varying scales can readily implement AI, promoting improved patient outcomes and enhancing the overall care experience. Elad Walach, Aidoc's CEO, said, We're excited about Mayo Clinic Platform's vision to transform care at scale. Together we are improving clinical workflows, enhancing patient outcomes and driving the evolution of healthcare through the power of AI. [Source – Cision PR Newswire] Mayo Clinic has integrated Aidoc's innovative AI solutions for clinical decision support since 2020. Its collaboration with Mayo Clinic Platform is expanding access to these advanced tools for a broader range of healthcare providers and patients. Aidoc's offerings encompass 13 FDA-cleared image and partner algorithms, facilitating the prioritization of clinical findings. It also has a built-in risk stratification system, a mobile app for real-time notifications in time-sensitive cases, and seamless integration of EHR data, which makes it easier for people from different departments to talk to each other and coordinate care. Aidoc's aiOS system confronts prevalent issues integrating artificial intelligence within practical healthcare environments. These challenges encompass the management of unstructured data, the efficient utilization of staff resources, the quantification of return on investment, and the resolution of fragmented organizational structures. About Aidoc Aidoc is a pioneering force in clinical AI, focusing on aiding and empowering healthcare teams to optimize patient treatment, resulting in improved economic value and clinical outcomes. Aidoc's proprietary aiOS builds the foundation for analyzing and aggregating medical data, enabling care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient. Used in more than 1,000 medical centers worldwide, Aidoc has the most FDA clearances (13) in clinical AI, and its AI-based solutions cover 75% of patient populations, enabling physicians to make informed decisions based on real-time data.